JCR Pharmaceuticals Co., Ltd.

TSE:4552 株式レポート

時価総額:JP¥84.8b

JCR Pharmaceuticals 将来の成長

Future 基準チェック /36

JCR Pharmaceuticals利益と収益がそれぞれ年間25.4%と3.2%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に7.8% 25.4%なると予測されています。

主要情報

25.4%

収益成長率

25.4%

EPS成長率

Pharmaceuticals 収益成長13.2%
収益成長率3.2%
将来の株主資本利益率7.8%
アナリストカバレッジ

Good

最終更新日31 Oct 2024

今後の成長に関する最新情報

Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Aug 03
Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Sep 06
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

Sep 04
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Aug 23
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Aug 09
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Aug 03
Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

Jul 26
JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

業績と収益の成長予測

TSE:4552 - アナリストの将来予測と過去の財務データ ( )JPY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202741,7245,1964,181N/A7
3/31/202641,2154,8017,283N/A7
3/31/202541,5635,0699,780N/A7
9/30/202435,256-437N/AN/AN/A
6/30/202440,2084,098N/AN/AN/A
3/31/202442,8715,5077,2179,312N/A
12/31/202341,3655,364N/AN/AN/A
9/30/202343,0348,063-9,017-952N/A
6/30/202335,5454,014N/AN/AN/A
3/31/202334,3433,772-14,060-5,500N/A
12/31/202237,5085,154N/AN/AN/A
9/30/202238,2806,2354,85713,009N/A
6/30/202250,87514,343N/AN/AN/A
3/31/202251,08214,507-2,0449,289N/A
12/31/202150,93116,549N/AN/AN/A
9/30/202147,51714,899-6,4951,362N/A
6/30/202134,7177,657N/AN/AN/A
3/31/202130,0856,8922,81410,341N/A
12/31/202026,1284,137N/AN/AN/A
9/30/202024,4962,9831,0406,210N/A
6/30/202024,8073,076N/AN/AN/A
3/31/202024,7812,678894,927N/A
12/31/201925,7093,653N/AN/AN/A
9/30/201924,1213,260114,482N/A
6/30/201923,6383,802N/AN/AN/A
3/31/201923,1603,7153,0103,905N/A
12/31/201820,8742,454N/AN/AN/A
9/30/201820,6822,5662,7103,675N/A
6/30/201820,8852,857N/AN/AN/A
3/31/201820,5943,070N/A3,133N/A
12/31/201720,2332,930N/AN/AN/A
9/30/201719,7382,722N/A2,572N/A
6/30/201718,6702,079N/AN/AN/A
3/31/201718,0851,863N/A2,651N/A
12/31/201617,4831,668N/AN/AN/A
9/30/201617,1901,751N/A1,017N/A
6/30/201617,0911,620N/AN/AN/A
3/31/201617,4381,789N/A2,201N/A
12/31/201517,5942,299N/AN/AN/A
9/30/201517,4822,281N/A2,853N/A
6/30/201517,1921,861N/AN/AN/A
3/31/201516,8551,682N/A499N/A
12/31/201416,3801,066N/AN/AN/A
9/30/201416,5161,319N/A2,795N/A
6/30/201416,1171,316N/AN/AN/A
3/31/201415,7051,296N/A4,565N/A
12/31/201315,6691,517N/AN/AN/A

アナリストによる今後の成長予測

収入対貯蓄率: 4552は今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 0.3% ) よりも高い成長率であると考えられます。

収益対市場: 4552今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: 4552今後 3 年以内に収益を上げることが予想されます。

収益対市場: 4552の収益 ( 3.2% ) JP市場 ( 4.2% ) よりも低い成長が予測されています。

高い収益成長: 4552の収益 ( 3.2% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 4552の 自己資本利益率 は、3年後には低くなると予測されています ( 7.8 %)。


成長企業の発掘